Second Ebola vaccine introduced in the DRC

 

 

Authorities in the Democratic Republic of Congo Thursday introduced a second vaccine to fight the deadly Ebola virus in the east of the country, the Doctors Without Borders (MSF) charity said.

It said the new vaccine, produced by a Belgian subsidiary of Johnson & Johnson, is aimed at protecting about 50 000 people over a period of four months.

More than 250 000 people in the region have already been received doses of another anti-Ebola vaccine since last year.

DR Congo declared an Ebola epidemic in August 2018 in the conflict-wracked eastern provinces of North Kivu, South Kivu and Ituri, bordering Uganda, Rwanda and Burundi.

The highly contagious haemorrhagic fever has so far killed 2 193 people, according to the latest official figures.

Efforts to roll back the epidemic have been hampered not only by fighting but also by resistance within communities to preventative measures, care facilities and safe burials.

Health workers battling Ebola have been attacked 300 times, leaving six people dead and 70 wounded since the start of the year, the country’s health minister said earlier this month.

Early on Thursday, about 15 people received an injection in one of two MSF centres in the North Kivu capital of Goma, a spokeswoman for the charity said.

Two-dose vaccine

MSF said in a statement on Tuesday that those receiving the first dose of the new vaccine would be asked to return to complete the process.

It said launching the programme in Goma would allow authorities “to check on the success of the two-dose vaccination in a city of one million people, in a region with a mobile population and where there have been cases in the past”.

At least two Ebola cases have been registered in Goma in July and August.

But the epicentre of the disease is about 350 kilometres north of Goma in the Beni-Butembo region.

It is the DRC’s 10th Ebola epidemic and the second deadliest on record after an outbreak that struck West Africa in 2014 to 16, claiming more than 11 300 lives.

The new J&J vaccine had initially been rejected by DRC’s former health minister Oly Ilunga, who cited the risks of introducing a new product in communities where mistrust of Ebola responders is already high.

But Ilunga’s resignation in July appears to have paved the way for approval of the second vaccine. He currently faces charges that he embezzled funds intended for the fight against Ebola.

© Agence France-Presse

Agency
External source
Advertisting

Workers’ R60m ‘lost’ in banks scam

An asset manager, VBS Mutual Bank and a Namibian bank have put the retirement funds of 26 000 municipal workers in South Africa at risk

‘Judge President Hlophe tried to influence allocation of judges to...

Deputy Judge President Patricia Goliath accuses Hlophe of attempting to influence her to allocate the case to judges he perceived as ‘favourably disposed’ to former president Jacob Zuma

SAA grounds flights due to low demand

SAA is working to accommodate customers on its sister airlines after it cancelled flights due to low demand

Lekwa municipality won’t answer questions about why children died in...

Three children are dead. More than a dozen homes have been gutted by fires in the past six months. And, as...
Advertising

Press Releases

MTN unveils TikTok bundles

Customised MTN TikTok data bundles are available to all prepaid customers on *136*2#.

Marketers need to reinvent themselves

Marketing is an exciting discipline, offering the perfect fit for individuals who are equally interested in business, human dynamics and strategic thinking. But the...

Upskill yourself to land your dream job in 2020

If you received admission to an IIE Higher Certificate qualification, once you have graduated, you can articulate to an IIE Diploma and then IIE Bachelor's degree at IIE Rosebank College.

South Africans unsure of what to expect in 2020

Almost half (49%) of South Africans, 15 years and older, agree or strongly agree that they view 2020 with optimism.

KZN teacher educators jet off to Columbia University

A group of academics were selected as participants of the programme focused on PhD completion, mobility, supervision capacity development and the generation of high-impact research.

New-style star accretion bursts dazzle astronomers

Associate Professor James O Chibueze and Dr SP van den Heever are part of an international team of astronomers studying the G358-MM1 high-mass protostar.

2020 risk outlook: Use GRC to build resilience

GRC activities can be used profitably to develop an integrated risk picture and response, says ContinuitySA.

MTN voted best mobile network

An independent report found MTN to be the best mobile network in SA in the fourth quarter of 2019.